DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Cello World Limited — Updates

NSE 2 hrs ago·7 Aug 2026, 2:33 pm

Cello World

Cello World Limited has informed the stock exchanges about its financial results for the quarter ended June 30, 2026. This update is a routine disclosure required for listed companies to keep the market informed about their business performance and financial health.

For investors, this announcement is a key milestone as it provides the first glimpse into the company's operations during the specified period. The reported figures will help the market assess Cello's current growth trajectory and operational efficiency.

Investors should focus on the company's revenue growth, profit margins, and any commentary on future outlook. Keeping an eye on the detailed financial statements will be crucial to understanding the company's performance and potential.